Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Vertex Provides Result Of Phase 2a Trial Evaluating VX-809
Reportedly, in the trial, VX-809 showed a decline in sweat chloride at both the 100mg and 200mg once-daily doses, suggesting that the activity of the CFTR protein was
Reportedly, in the trial, VX-809 showed a decline in sweat chloride at both the 100mg and 200mg once-daily doses, suggesting that the activity of the CFTR protein was
The NuroPro AD test was developed to help clinicians distinguish patients with Alzheimer’s disease from normal individuals and patients with other neurological disorders. The test, developed by Power3,
Dr Kobayashi will focus on expanding UBC’s operations in Japan with specific oversight on its line of services aimed at improving the reliability of clinical study results. Dr
Reportedly, in 2006, Health Discovery has sued Ciphergen Biosystems in Federal District Court for infringement of several of its patents covering the use of support vector machines (SVMs)
Henri Termeer, chairman and chief executive officer at Genzyme, said: “Scott Canute is among the very top people in the pharmaceutical manufacturing field. He is widely respected for
The company said that the purchase price is $110m cash subject to a customary working capital adjustment. The acquisition is expected to close in the first quarter of
Since 2005, TaconicArtemis, a German subsidiary of Taconic, has been working with its Scottish partner, CXR Biosciences (Dundee, Scotland) to deliver new, commercially viable, models that are more
The Helicos Genetic Analysis System is the molecule sequencing technology that enables scientists to conduct revolutionary studies to understand genome biology and regulation. Genetic analysis with Helicos’ technology
The company said that the complaint alleges that certain processes and methods performed by XenoTech associated with its in-vitro drug testing services and its pooled cryopreserved hepatocyte products,
Millipore’s fourth quarter earnings per share were $0.78 per share, compared to $0.56 per share in the fourth quarter of 2008. Non-GAAP earnings per share were $1.00, compared